Author
Georg Fluegen
Also Known As
F Klingler, G Fluegen, G. Fluegen, Georg Fluegen, M Distler
57
Publications
1.2K
Citations
15
H-Index
27
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 5 | 5 | 450 |
2 | Health Sciences | 2 | 2 | 72 |
3 | Cell Biology | 1 | 1 | 342 |
4 | Gastroenterology | 1 | 1 | 21 |
5 | Medical Laboratory Science | 1 | 1 | 57 |
Georg Fluegen
×
15
Publications
789
Citations
13
H-Index
| Year | Citations | |
|---|---|---|
2017 | 342 | |
2023 | 122 | |
2012 | 61 | |
2019 | 57 | |
2013 | 42 | |
2022 | 31 | |
2017 | 21 | |
2021 | 21 | |
2021 | 15 | |
5-(Trifluoromethyl)-1,2,4-oxadiazole (TFMO)-based highly selective class IIa HDAC inhibitors exhibit synergistic anticancer activity in combination with bortezomib Yodita Asfaha, Lukas M. Bollmann, Alexander Jan Skerhut, European Journal of Medicinal Chemistry Medicinal ChemistryOncologyHealth SciencesMedicinePharmacological Agent | 2023 | 15 |
Page 1
Page 1